"Lymphoma, T-Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of heterogeneous lymphoid tumors representing malignant transformations of T-lymphocytes.
Descriptor ID |
D016399
|
MeSH Number(s) |
C04.557.386.480.750 C15.604.515.569.480.750 C20.683.515.761.480.750
|
Concept/Terms |
Lymphoma, T-Cell- Lymphoma, T-Cell
- Lymphoma, T Cell
- T-Cell Lymphoma
- Lymphomas, T-Cell
- T Cell Lymphoma
- T-Cell Lymphomas
|
Below are MeSH descriptors whose meaning is more general than "Lymphoma, T-Cell".
Below are MeSH descriptors whose meaning is more specific than "Lymphoma, T-Cell".
This graph shows the total number of publications written about "Lymphoma, T-Cell" by people in this website by year, and whether "Lymphoma, T-Cell" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 6 | 0 | 6 |
1996 | 3 | 1 | 4 |
1997 | 2 | 0 | 2 |
1998 | 1 | 1 | 2 |
1999 | 4 | 0 | 4 |
2000 | 3 | 0 | 3 |
2001 | 5 | 2 | 7 |
2002 | 6 | 2 | 8 |
2003 | 3 | 2 | 5 |
2004 | 5 | 1 | 6 |
2005 | 4 | 4 | 8 |
2006 | 6 | 0 | 6 |
2007 | 6 | 0 | 6 |
2008 | 5 | 1 | 6 |
2009 | 7 | 1 | 8 |
2010 | 4 | 1 | 5 |
2011 | 7 | 1 | 8 |
2012 | 1 | 1 | 2 |
2013 | 6 | 1 | 7 |
2014 | 5 | 0 | 5 |
2015 | 10 | 3 | 13 |
2016 | 5 | 0 | 5 |
2017 | 3 | 0 | 3 |
2018 | 3 | 0 | 3 |
2019 | 8 | 0 | 8 |
2020 | 6 | 0 | 6 |
2021 | 2 | 1 | 3 |
2022 | 4 | 0 | 4 |
2023 | 1 | 0 | 1 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lymphoma, T-Cell" by people in Profiles.
-
Safety and efficacy of tenalisib in combination with romidepsin in patients with relapsed/refractory T-cell lymphoma: results from a phase I/II open-label multicenter study. Haematologica. 2024 Jan 01; 109(1):209-219.
-
Chimeric Antigen Receptor T Cells in Hodgkin and T-Cell Lymphomas. Hematol Oncol Clin North Am. 2023 Dec; 37(6):1107-1124.
-
Clinical and Pathological Characteristics and Outcomes Among Patients With Subcutaneous Panniculitis-like T-Cell Lymphoma and Related Adipotropic Lymphoproliferative Disorders. JAMA Dermatol. 2022 Oct 01; 158(10):1167-1174.
-
Expression pattern and diagnostic utility of BCL11B in mature T- and NK-cell neoplasms. Pathology. 2022 Dec; 54(7):893-899.
-
T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022 03; 20(3):285-308.
-
Breast T-Lymphoblastic Lymphoma Presenting as a Single Mass in a Young Female with Family History of Breast Cancer. Int J Surg Pathol. 2022 Oct; 30(7):760-768.
-
Haemophagocytic lymphohistiocytosis and Epstein-Barr virus: a complex relationship with diverse origins, expression and outcomes. Br J Haematol. 2022 01; 196(1):31-44.
-
CD94 expression patterns in reactive and neoplastic T-cell and NK-cell proliferations. Leuk Res. 2021 09; 108:106614.
-
Early central nervous system relapse of monomorphic epitheliotropic intestinal T-cell lymphoma after cord blood transplantation. Int J Hematol. 2021 Jul; 114(1):129-135.
-
NCCN Guidelines Insights: T-Cell Lymphomas, Version 1.2021. J Natl Compr Canc Netw. 2020 11 02; 18(11):1460-1467.